Instem And Proscia Partner To Accelerate Preclinical Development With Digital Pathology
17 Junio 2024 - 7:00AM
Instem, a leading provider of IT solutions and services to the
global life sciences market, has partnered with Proscia®, a global
leader in AI-enhanced pathology solutions for precision medicine.
Through the collaboration, the companies will deliver a unified
customer experience around Instem’s Provantis® preclinical study
management solution and Proscia’s Concentriq® for Research software
platform to accelerate toxicologic pathology and other preclinical
studies.
The unified customer experience will center on a joint product
integration that seamlessly incorporates Provantis users’ data into
Concentriq for Research's purpose-built digital pathology
workflows. In doing so, the integration will enable them to speed
up primary and peer review assessments, streamline collaboration,
and simplify GLP compliance in one software platform so they can
conduct regulated and non-regulated studies faster and make more
informed decisions. Concentriq is trusted by 14 of the top 20
pharmaceutical companies as well as leading contract research
organizations.
“Proscia has established itself as a leader in its space,” said
Carlos Frade, VP of Corporate and Market Development at Instem.
“We’ve recently enhanced Provantis to increasingly support digital
pathology workflows. Partnering with Proscia and integrating with
its Concentriq platform are the obvious next steps in helping our
customers realize the full potential of the shift from microscope
to images.”
In entering into this collaboration, Instem will also join the
Proscia Ready partner alliance, furthering the companies’
commitment to customer experience. Proscia Ready is made up of
solution providers helping laboratories and life sciences
organizations accelerate the scaled adoption of digital pathology
with confidence. It delivers on this aim through a shared focus on
product integration, joint support agreements, and a collective
vision for future innovation.
“Preclinical development teams are among the biggest
beneficiaries of digital pathology given that their studies involve
massive volumes of data,” said Stephan Fromme, Head of Strategic
Alliances at Proscia. “Partnering with Instem will enable us to
better help our shared base of world-class customers get to
clinical trials faster and hopefully bring new therapies to
patients sooner.”
Instem and Proscia are exhibiting at the Society of Toxicologic
Pathology 43rd Annual Symposium. Visit Instem at booth 200 and
Proscia at booth 105 to learn more about the partnership and see
live demos of their solutions.
About InstemA global provider of leading
software solutions, technology enabled outsourced services and
powerful scientific insights, Instem is helping clients to bring
their life enhancing products to market faster.
We enable organizations in the life sciences to more efficiently
collect, report and submit high quality regulatory data, while
offering them the unique ability to generate new knowledge through
the extraction and harmonization of actionable scientific
information.
Every day, across the entire drug development value chain,
Instem solutions are meeting the rapidly expanding needs of life
science organizations for data-driven decision making, leading to
safer, more effective products.
Instem supports its global roster of clients through offices in
the United States, United Kingdom, France, Japan, China, and
India.
About ProsciaProscia is a software company
accelerating the transformation to digital pathology to change the
way we understand diseases like cancer. Its Concentriq enterprise
pathology platform and powerful AI applications are advancing the
150-year-old standard of research and diagnosis towards a
data-driven discipline, unlocking new insights that accelerate
R&D, improve patient outcomes, and fulfill the promise of
precision medicine. Leading diagnostic laboratories and 14 of the
top 20 pharmaceutical companies rely on Proscia’s software each
day. For more information, visit proscia.com.
ContactSydney FenkellHead Of Marketing
Communications215-816-3436sydney@proscia.com